For these reasons, the CRC diagnostic outcomes across a comprehensive range of f-Hb thresholds in a wide spectrum of patients who presented with lower GI symptoms and had FIT in primary care were studied. This evidence concerns the gene GSTM1 and colorectal carcinoma.